Discontinuation report LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Report ID | 79452 |
Drug Identification Number | 01901915 |
Brand name | LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:100 000 INJECTION USP |
Common or Proper name | Lidocaine Hydrochloride and Epinephrine Injection USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LIDOCAINE HYDROCHLORIDE EPINEPHRINE |
Strength(s) | 20MG 10MCG |
Dosage form(s) | SOLUTION |
Route of administration | BLOCK/INFILTRATION |
Packaging size | 25 x 50mL GVL MD |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2019-03-25 |
Remaining supply date | 2019-03-25 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2019-03-26 | French | Compare |
v1 | 2019-03-26 | English | Compare |
Showing 1 to 2 of 2